Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 4/20 | 0.78 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.78 |
| ▸ | SRC | P12931 | 2/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.78 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.78 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.78 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.78 |
| ▸ | LDHA | P00338 | 1/20 | 0.78 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.78 |
| ▸ | FBP1 | P09467 | 1/20 | 0.78 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.78 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.78 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.78 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.78 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.78 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.78 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.78 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.78 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.78 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Phosphate SCHEMBL3861077 | 1.00 | P2RY1 (0.78) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 | |
| Adenosine Phosphate SCHEMBL14812251 | 1.00 | P2RY1 (0.78) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 | |
| Adenosine Phosphate SCHEMBL14812127 | 0.95 | P2RY1 (0.71) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 | |
| Adenosine Phosphate SCHEMBL26624787 | 0.94 | P2RY1 (0.77) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 | |
| Adenosine Phosphate SCHEMBL1270930 | 0.94 | P2RY1 (0.77) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 | |
| Adenosine Phosphate SCHEMBL14811832 | 0.94 | P2RY1 (0.69) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 | |
| Adenosine Phosphate SCHEMBL2515775 | 0.92 | P2RY1 (0.81) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 | |
| Adenosine Phosphate SCHEMBL26624775 | 0.91 | P2RY1 (0.71) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 | |
| Adenosine Phosphate SCHEMBL2512991 | 0.90 | P2RY2 (0.78) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 | |
| Adenosine Phosphate SCHEMBL8591984 | 0.90 | P2RY1 (0.81) | P2RY1P2RY2SRCSMN1; SMN2DNPH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4514307-B1 | AERATED COSMETIC COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-09-03 | — | — | EP | claimed |
| US-20250268810-A1 | AERATED COSMETIC COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2025-08-28 | — | — | US | claimed |
| WO-2025133938-A1 | A HAIR BLEACH AND COLOUR DEPOSITION FORMULATION AND METHOD OF PREPARATION THEREOF | MARICO LIMITED (IN) | 2025-06-26 | — | — | WO | claimed |
| EP-4514307-A1 | AERATED COSMETIC COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-03-05 | — | — | EP | claimed |
| CN-119546270-A | Aerated cosmetic composition | 联合利华知识产权控股有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-12233144-B2 | Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors | CONOPCO, INC. (US) | 2025-02-25 | — | — | US | claimed |
| US-12070516-B2 | Hair styling compositions | L'OREAL (FR) | 2024-08-27 | — | — | US | claimed |
| US-20240197597-A1 | HAIR STYLING COMPOSITIONS | L'OREAL (FR) | 2024-06-20 | — | — | US | claimed |
| CN-117771152-B | Skin-tendering anti-wrinkle bifidobacterium longum SF-B-60 fermentation product and preparation method and application thereof | 妙越缇卡生物医药科技(山东)有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-117771152-A | Skin-tendering anti-wrinkle bifidobacterium longum SF-B-60 fermentation product and preparation method and application thereof | 妙越缇卡生物医药科技(山东)有限公司 | 2024-03-29 | — | — | CN | claimed |
| WO-2023208618-A1 | AERATED COSMETIC COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-11-02 | — | — | WO | claimed |
| US-20220370965-A1 | METHOD, SYSTEM, APPARATUS AND FORMULATIONS FOR PRODUCING OIL-BASED BLENDS AND MICROEMULSIONS AND NANOEMULSIONS | FERNANDES SERODIO JOAO CARLOS (GB) | 2022-11-24 | — | — | US | claimed |
| EP-4055127-A1 | METHOD, SYSTEM, APPARATUS AND FORMULATIONS FOR PRODUCING OIL-BASED BLENDS AND MICROEMULSIONS AND NANOEMULSIONS | Fernandes Serodio, Joao Carlos (GB) | 2022-09-14 | — | — | EP | claimed |
| US-20220226214-A1 | METHOD FOR STABILIZING RETINOIC ACID PRECURSORS AND A SKIN BENEFIT COMPOSITION WITH STABILIZED RETINOIC ACID PRECURSORS | CONOPCO, INC., D/B/A UNILEVER (US) | 2022-07-21 | — | — | US | claimed |
| US-11324679-B2 | Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors | CONOPCO, INC. (US) | 2022-05-10 | — | — | US | claimed |
| CN-112823786-A | Pharmaceutical composition containing meloxicam and application | 北京泰德制药股份有限公司 | 2021-05-21 | — | — | CN | claimed |
| US-20160120803-A1 | NON-AEROSOL FOAMS FOR TOPICAL ADMINISTRATION | CONTRACT PHARMACEUTICALS LIMITED (CA) | 2016-05-05 | — | — | US | claimed |
| EP-3010487-A1 | NON-AEROSOL FOAMS FOR TOPICAL ADMINISTRATION | Contract Pharmaceuticals Limited (CA) | 2016-04-27 | — | — | EP | claimed |
| WO-2014201541-A1 | NON-AEROSOL FOAMS FOR TOPICAL ADMINISTRATION | CONTRACT PHARMACEUTICALS LIMITED (CA) | 2014-12-24 | — | — | WO | claimed |
| US-8349301-B2 | Mixture of surfactants, fatty amphiphiles and aqueous carrier | THE PROCTER & GAMBLE COMPANY (US) | 2013-01-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12233144-B2 | Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors | RARA, RARB, RBP4 | P2RY1 4537/4885P2RY2 4586/4885SRC 4763/4885 |
| US-20220226214-A1 | METHOD FOR STABILIZING RETINOIC ACID PRECURSORS AND A SKIN BENEFIT COMPOSITION WITH STABILIZED RETINOIC ACID PRECURSORS | RARA, RARB, RBP4 | P2RY1 4537/4885P2RY2 4586/4885SRC 4763/4885 |
| US-11324679-B2 | Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors | RARA, RARB, RBP4 | P2RY1 4537/4885P2RY2 4586/4885SRC 4763/4885 |
| US-20240197597-A1 | HAIR STYLING COMPOSITIONS | PIK3C3, POLR1C, ALKBH3 | P2RY1 3769/4885P2RY2 3380/4885SRC 787/4885 |
| US-12070516-B2 | Hair styling compositions | PIK3C3, POLR1C, ALKBH3 | P2RY1 3769/4885P2RY2 3380/4885SRC 787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.